Weekly shot helps asians with obesity shed pounds in major trial
NCT ID NCT04998136
First seen Oct 31, 2025 · Last updated Jun 09, 2026 · Updated 27 times
Summary
This study tested whether a weekly injection of semaglutide (2.4 mg) helps Asian adults with obesity (BMI 25 or higher) lose weight. About 150 participants received either the drug or a placebo for 44 weeks, along with diet and exercise advice. The main goal was to see how much weight they lost. The drug is meant to be taken long-term to keep weight off, so it controls the condition rather than curing it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ajou University Hospital
Suwon, 16499, South Korea
-
Dongguk University Ilsan Hospital_Gyeonggi-do
Gyeonggi-do, 10326, South Korea
-
Gachon University Gil Hospital
Incheon, 405-760, South Korea
-
Hallym University Sacred Heart Hospital
Gyeonggi-do, 14068, South Korea
-
King Chulalongkorn Memorial Hospital_Bangkok
Bangkok, 10330, Thailand
-
King Chulalongkorn Memorial Hospital_Endocrinology
Bangkok, 10330, Thailand
-
King Chulalongkorn Memorial Hospital_Obstetrics&Gynecology
Bangkok, 10330, Thailand
-
Konyang University Hospital
Daejeon, 35365, South Korea
-
Maharaj Nakorn Chiang Mai_Hematology and Oncology
Chiang Mai, 50200, Thailand
-
Obstetrics&Gynecology King Chulalongkorn Memorial Hospital
Bangkok, 10330, Thailand
-
Ramathibodi Hospital_Nutrition and Biochemical
Bangkok, 10400, Thailand
-
SMG-SNU Boramae Medical Center
Seoul, 07061, South Korea
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, 13620, South Korea
-
Siriraj Hospital_Bangkok_1
Bangkok, 10700, Thailand
-
Siriraj Hospital_Dept Cardio
Bangkok, 10700, Thailand
-
Siriraj Institute of Clinical Research
Bangkok, 10700, Thailand
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.